Navigation Links
Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Date:5/5/2011

ndocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. The safety and effectiveness of Afinitor in the treatment of patients with carcinoid tumors have not been established.

For more information visit www.AFINITOR.com/pNET or call 1-888-4-AFINITOR. US patients who may be eligible for financial assistance can learn about the Patient Assistance Now Oncology (PANO) reimbursement support program by contacting 1-800-282-7630 or visiting the Afinitor website.

Afinitor is approved in the US for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib and in the European Union (EU) for the treatment of patients with advanced RCC whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted therapy.

Afinitor is also approved in the US to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of Afinitor is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been shown. Novartis has submitted marketing applications for everolimus for this use to the European Medicines Agency (EMA) and the Swiss Agency for Therapeutic Products (Swissmedic), and additional regulatory submissions are under way worldwide.

Afinitor is available in the US in 2.5 mg, 5 mg and 10 mg tablet strengths.

In the US, everolimus is available in different dosage strengths for the non-oncology patient population under the trade name Zortress® for the prophylaxis of organ rejection in adult patients at low-moderate immunologic risk receiving a kidney transplant. In the EU, everolimus is available in different
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
4. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
5. Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients
6. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
7. Final Approval of Novartis Gender Discrimination Settlement Slated for November 19
8. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Novartis to Expand Global Research Headquarters in Cambridge, MA
11. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... /PRNewswire-iReach/ -- United Medical Education, a company that provides ... Advanced Life Support (PALS) and Basic Life Support (BLS), ... online course manuals. In order to gain access ... an account with the company. By offering the free ... Education is setting a precedent among similar companies. ...
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will ... Ken Berger , CEO, and Ed Borkowski ... ET live via telephone. To participate in the conference ... 366-0267. To participate in the conference call outside the U.S. ... The conference ID is 72195398. Participants should dial in 10 ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2
... ... activity -, - ... patients -, SAN DIEGO, June 25 Ardea Biosciences, Inc.,(Nasdaq: ... 2a proof-of-concept monotherapy study of RDEA806, its novel,investigational non-nucleoside reverse transcriptase ...
... DIEGO, June 25 Mpex Pharmaceuticals, Inc. today,announced ... study with MP-376 for,the treatment of pulmonary infections ... with cystic fibrosis. MP-376 is Mpex,s,proprietary aerosol formulation ... key bacterial pathogens, including Pseudomonas,aeruginosa. Delivery of levofloxacin ...
Cached Medicine Technology:Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 2Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 3Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 4Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients 2Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients 3
(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... Minor fender benders and serious car accidents ... to the accident to respond appropriately to the situation. ... (CDC) data from 2010, accidents, including car accidents, are ... fact, in 2005, automobile accident-related deaths cost ... 2.3 million drivers and passengers receive treatment in an ...
(Date:5/19/2013)... 19, 2013 The Da Vinci robot ... developments in the nation’s first trial involving a Da ... Washington State Superior Court, was filed by the widow ... suffered complications in a robot-assisted prostate removal, according to ... Vinci robotic surgery lawsuit alleges those complication’s hastened ...
(Date:5/18/2013)... May 19, 2013 In “Cooking with Spirits ... iUniverse) , author Janet Hall Svisdahl’s new cookbook, readers are ... sure to make even the pickiest eater drool. “I dedicate ... prayerfully,” she explains. , Found within the 364 pages ... range of delicious recipes, from fast and simple to gourmet. ...
(Date:5/18/2013)... Society for Gastrointestinal Endoscopy (ASGE) will honor important contributions ... ASGE Crystal Awards on Sunday, May 19, 2013. Hosted ... will begin at 6:30 p.m. ... conjunction with Digestive Disease Week (DDW), the ASGE Crystal ... pursuit. The event will recognize the 2013 award and ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7
... limited pressure to achieve the ,thin and beautiful, ideal have ... study looking at five factors that may help young women ... of a society where discontent with appearance is common among ... of Arizona in the US, and colleagues is published online ...
... stimulating immune cells to more effectively battle cancerous tumors, ... effect, driving these intracellular fighters to exhaustion, a Mayo ... Journal of Clinical Investigation . The ... testing the treatment,s ability to ramp up the body,s ...
... News) -- Children who wake up at night and are allowed ... to be overweight than kids put back into their own bed, ... children aged 2 to 6 who had an increased risk of ... were overweight before becoming pregnant or their mothers were poor. ...
... News) -- Everyone knows teen behavior is highly influenced by their ... influence whether or not a teen drinks alcohol or uses drugs. ... their child,s drug or alcohol use, or worse, condone it, that ... study found. "Among friendship groups with ,good parents, there,s a ...
... HealthDay Reporter , TUESDAY, May 8 (HealthDay News) -- Women who ... to worry about gaining weight after the device is implanted, new ... aged 15 to 44 who were using two different types of ... About half of the women had a non-hormonal IUD containing copper ...
... A Wayne State University researcher believes a better ... one day help at-risk adolescents transition more quickly to ... To further that understanding, Tim Bogg, Ph.D., assistant ... and Sciences, has received a three-year, $731,000 grant from ...
Cached Medicine News:Health News:Self-worth needs to go beyond appearance 2Health News:Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment 2Health News:Study: Kids Who Sleep in Parents' Bed Less Likely to Be Overweight 2Health News:Friends' Parents Can Sway Teens' Odds for Drinking, Smoking 2Health News:IUD Use Tied to Modest Weight Loss 2Health News:IUD Use Tied to Modest Weight Loss 3Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 2Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: